Blank Bio

Blank Bio is developing advanced foundation models designed to interpret RNA, the fundamental language of life. These models are engineered to enhance various stages of the research and development process, facilitating the creation of improved drugs and the execution of more efficient clinical trials. Their initial model excels in predicting mRNA properties, offering simulations of expensive experiments to enable partners to design superior mRNA medicines with greater speed and reduced costs. Open-source versions of their models are currently utilized by leading pharmaceutical companies such as Sanofi and GSK. Furthermore, they are partnering with the Arc Institute to integrate their RNA embeddings into advanced virtual cell models. While their current focus is on mRNA design, Blank Bio intends to expand the model's capabilities to encompass applications such as target identification, novel biomarker discovery, and patient stratification. The team possesses extensive experience in applying machine learning to biological challenges, gained through doctoral studies at the University of Toronto and industry experience at companies like Recursion, Deep Genomics, and Amazon. For further information, please contact founders@blank.bio.